Yulug, B., Altay, O., Li, X., Hanoglu, L., Cankaya, S., Lam, S., . . . Mardinoglu, A. (2023). Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: A randomised, double-blinded, placebo-controlled phase-II trial. BMC.
Chicago Style (17th ed.) CitationYulug, Burak, et al. Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomised, Double-blinded, Placebo-controlled Phase-II Trial. BMC, 2023.
MLA (9th ed.) CitationYulug, Burak, et al. Combined Metabolic Activators Improve Cognitive Functions in Alzheimer’s Disease Patients: A Randomised, Double-blinded, Placebo-controlled Phase-II Trial. BMC, 2023.
Warning: These citations may not always be 100% accurate.